A6 How to empower our patients

Wednesday 31 August 2016
Hilton Buenos Aires : Pacifico A, 1.5 hours

Organised by the FIP Health and Medicines Information Section (HaMIS)

Simultaneous translation in Spanish



Problems that patients experience with their medicines range from inappropriate use to medicine errors and adverse events. Adherence to medicines and chronic therapy is one of the most significant challenges encountered by patients, as demonstrated by the low adherence levels seen across a range of medical conditions and therapeutic drug classes. Globally, people are living longer and with chronic conditions that require chronic therapy. Thus, medicines are becoming an important part of people’s lives, and the rational use of medicines is becoming a desirable skill for all people. Different countries have applied different methods to increase the rational use of medicines at a population level, such as education through schools, nationwide annual campaigns, peer-education programmes and interactive websites. These methods aim to empower patients.

Learning objectives 

At the conclusion of this application-based session, participants will be able to:

  1. Analyse the range of methods use to empower medicine users at a population level
  2. Advocate the relationship between health literacy and rational use of medicines
  3. Demonstrate how interprofessional collaboration as well as collaboration with patients, through a patient-centred approach, can promote rational use of medicines
  4. Adopt strategies that can be implemented to promote rational use of medicines at a population level. 


Katri Hämeen-Anttila (FIP HaMIS, Finland) and Victoria Hall Ramírez (FIP HaMIS, Costa Rica) 




1) USA: Utilising pharmaceutical practice to empower patients

Henri Manasse (American Society of Health-System Pharmacists, USA)


2) School-level education as a method for empowering future medicine users in Finland

Katri Hämeen-Anttila (FIP HaMIS, Finland)

3)      Examples of activities to empower citizens to use medicines rationally


a)      Costa Rica: Therapeutic follow-up, experiences from recent actions

Victoria Hall Ramirez (University of Costa Rica, Costa Rica)


b)      Peru: Pharmaceutical care campaign as a strategy for implementation of pharmaceutical services

Aldo Alvarez-Risco (Ministry of Health, Peru)


c)       Argentina and Spain: The development of pharmaceutical services in community pharmacies and its impact on patient outcomes

Pedro Armando (National University of Cordoba, Argentina)